ConductScience.org, home

Trial · NCT07907952

tSCS Combined With Rehabilitation Training in Treating Paraplegic Patients After SCI

NCT07907952, Not applicable, Recruiting, Beijing Tsinghua Chang Gung Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. tSCS Combined With Rehabilitation Training in Treating Paraplegic Patients After SCI. Trials, record NCT07907952. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907952

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
tSCS Combined With Rehabilitation Training in Treating Paraplegic Patients After SCI
NCT number
NCT07907952
Status
Recruiting
Phases
Not applicable
Enrollment
10 participants, estimated
Lead sponsor
Beijing Tsinghua Chang Gung Hospital
Conditions
Spinal Cord Injury, Paraplegia, Spinal
Interventions
Transcutaneous Spinal Cord Stimulation Combined with Rehabilitation Training
First posted
2026-10-30
Last updated
2026-10-30

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryWalking Index for Spinal Cord Injury, WISCI ⅡBaseline、Week 1 of Stimulation and Completion of experiment
The commonly used ordinal scale in clinical trials to measure walking ability in patients with spinal cord injury. Based on the severity of walking impairment, the walking function is divided into 21 levels (from level 0, where patients cannot stand or walk, to level 20, where patients can walk at least 10 meters without facilities or assistance) based on the equipment, braces, and assistance required for patients to walk 10 meters.
Primary10-Meter Walk Test, 10MWTBaseline、Week 1 of Stimulation and Completion of experimentWalking speed test: measures the time required for patients to walk 10 meters, used to assess their short-distance walking ability.
PrimaryWeight Bearing Capacity, WBCBaseline、Week 1 of Stimulation and Completion of experimentIt is a crucial outcome that requires monitoring, especially for patients with severe motor disorders who are unable to walk independently.
SecondaryBerg Balance Scale, BBSBaseline、Week 1 of Stimulation and Completion of experiment
Used for clinical assessment of balance function. The assessment includes 14 items, with each item scored from 0 to 4 points, resulting in a total score of 56 points. The scores are divided into three groups: 0-20, 21-40, and 41-56, which correspond to three activity states: wheelchair use, assisted walking, and independent walking. If the total score is less than 40 points, it indicates a risk of falling.
Secondary36-Item Short Form Health Survey,SF-36Baseline、Week 1 of Stimulation and Completion of experiment
Including 36 items divided into 8 dimensions: physiological function, role-physical, bodily pain, general health, vitality, social function, role-emotional, and mental health. These dimensions belong to two major categories: physical health and mental health. The final score for each dimension ranges from 0 (lowest) to 100 (highest), with higher scores indicating better quality of life.
Secondary6-Min Walk Test, 6MWTBaseline、Week 1 of Stimulation and Completion of experimentThe walking speed test, which measures the distance a patient can walk in 6 minutes, reflects the overall functional status of the cardiorespiratory and musculoskeletal systems in daily activities.
SecondaryKinematic AssessmentBaseline、Week 1 of Stimulation and Completion of experiment
The three-dimensional motion capture system is used to obtain kinematic records (gait temporal parameters, spatial parameters; hip, knee, and ankle joint angles) of patients during walking. The system's infrared cameras capture human kinematics by using infrared reflective markers placed on anatomical landmarks. High-definition cameras are used to capture patients' timing photographic images, which demonstrate the dynamics of patient movement through superimposed consecutive snapshots.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07907952

GET https://conductscience.org/api/trials/v1/NCT07907952/registered